Global Absorbable Gelatin Sponge Market Size By Type (Large Size, Medium Size), By Application (Minimally Invasive Surgery, General Surgery), By Region, And Segment Forecasts, 2023 to 2032

The Global Absorbable Gelatin Sponge Market was valued at USD 965 million in 2023 and is expected to reach USD 1.65 billion by 2031, growing at a CAGR of 6.9% during the forecast period of 2023 to 2031. This growth is driven by the increasing prevalence of surgical procedures, rising awareness of effective hemostatic agents, and advancements in bioabsorbable material technologies. Absorbable gelatin sponges are primarily used in surgical procedures to control bleeding, offering advantages such as quick absorption, biocompatibility, and reduced risk of infection.

Drivers:

1. Surge in Surgical Procedures Worldwide:

The growing incidence of surgeries, particularly orthopedic, cardiovascular, and dental procedures, has significantly boosted the demand for hemostatic agents like absorbable gelatin sponges.

2. Advancements in Biocompatible Materials:

Continuous innovation in bioabsorbable technologies and improvements in sponge design for quicker absorption and superior performance are supporting market expansion.

3. Rising Geriatric Population:

An aging population is more prone to chronic diseases requiring surgical intervention, thus driving demand for effective hemostatic products.

Restraints:

1. Availability of Alternative Hemostats:

The market faces competition from other hemostatic agents like oxidized regenerated cellulose, thrombin, and synthetic sealants, which may limit the adoption of gelatin sponges in certain applications.

2. Risk of Allergic Reactions and Infections:

Despite being absorbable, gelatin sponges can occasionally cause inflammatory responses or infections, especially in sensitive patients, hampering their usage in specific cases.

Opportunity:

1. Growing Demand in Ambulatory Surgical Centers (ASCs):

The rise in outpatient surgeries and minimally invasive procedures creates new avenues for absorbable gelatin sponge applications due to their ease of use and rapid hemostasis.

2. Expansion into Emerging Markets:

With growing healthcare infrastructure in regions like Asia-Pacific and Latin America, there are significant opportunities for manufacturers to introduce cost-effective gelatin sponges to new markets.

Market by System Type Insights:

The Standard Gelatin Sponge segment held the largest market share in 2023, favored for its widespread use in general surgeries and cost-efficiency. However, the Antibiotic-Infused Gelatin Sponge segment is anticipated to witness the highest CAGR during the forecast period, owing to rising demand for infection prevention in surgical environments.

Market by End-use Insights:

By end-use, Hospitals dominated the market in 2023, accounting for over 60% of the global revenue. The presence of advanced surgical facilities and higher surgical volumes makes hospitals the key consumers. Meanwhile, Ambulatory Surgical Centers (ASCs) are projected to grow at a notable rate, propelled by the trend toward same-day surgeries and patient preference for cost-effective care.

Market by Regional Insights:

North America led the global absorbable gelatin sponge market in 2023, attributed to its developed healthcare infrastructure, high surgical volumes, and strong presence of leading manufacturers. Asia-Pacific is poised to register the fastest growth through 2031 due to rising healthcare spending, increasing awareness of surgical care, and improving access to medical devices in countries like China and India.

Competitive Scenario:

Key players in the Global Absorbable Gelatin Sponge Market include Pfizer Inc., Johnson & Johnson (Ethicon), Baxter International Inc., B. Braun Melsungen AG, Medtronic plc, CuraMedical BV, Ferrosan Medical Devices, and Gelita Medical GmbH. These companies are actively investing in R&D, product innovation, and strategic partnerships to strengthen their market positions.

Scope of Work – Global Absorbable Gelatin Sponge Market

Report Metric Details

Market Size (2023) USD 965 million

Projected Market Size (2031) USD 1.65 billion

CAGR (2023-2031) 6.9%

Market Segments By System Type (Standard, Antibiotic-Infused), By End-use (Hospitals, ASCs, Clinics), By Region

Growth Drivers Increase in surgical procedures, advancements in absorbable materials, rising geriatric population

Opportunities Adoption in ASCs, expansion in emerging markets

Key Market Developments:

2023: Johnson & Johnson (Ethicon) launched a next-gen gelatin sponge featuring faster hemostatic performance for complex surgical applications.

2024: B. Braun Melsungen AG expanded its production capacity in Europe to meet rising demand for surgical hemostats.

2025: Baxter International Inc. introduced a line of antibiotic-infused absorbable gelatin sponges to reduce post-surgical infections.

FAQs:

1. What is the current market size of the Global Absorbable Gelatin Sponge Market?

The market was valued at USD 965 million in 2023.

2. What is the major growth driver of the Global Absorbable Gelatin Sponge Market?

The primary driver is the increasing number of surgical procedures globally.

3. Which is the largest region during the forecast period in the Global Absorbable Gelatin Sponge Market?

North America holds the largest market share.

4. Which segment accounted for the largest market share in the Global Absorbable Gelatin Sponge Market?

The Standard Gelatin Sponge segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Absorbable Gelatin Sponge Market?

Pfizer Inc., Johnson & Johnson, Baxter International, Medtronic, and B. Braun Melsungen AG are some of the major players.